GENEVA, July 31 -- CHENGDU MFS PHARMA.CO., LTD. filed a patent application (CN2026/073928) for “ESTER HETEROCYCLIC COMPOUND AND USE THEREOF”. With publication no. WO/2026/158367, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 405/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....